Radiopharm Theranostics Limited (RAD.AX)
AUD 0.02
(-8.7%)
AUD 0.02
(-8.7%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -47.2 Million AUD | 9.11% |
| 2023 | -40.29 Million AUD | -68.4% |
| 2022 | -23.92 Million AUD | -4835.81% |
| 2021 | -484.75 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -38.46 Million AUD | 4.53% |
| 2024 Q4 | -19.35 Million AUD | -71.93% |
| 2024 Q2 | -23.13 Million AUD | -142.64% |
| 2024 Q1 | -9.53 Million AUD | 60.76% |
| 2024 Q3 | -11.25 Million AUD | 51.32% |
| 2023 FY | -40.29 Million AUD | -68.4% |
| 2023 Q3 | -8.28 Million AUD | 48.23% |
| 2023 Q1 | -5.52 Million AUD | 52.59% |
| 2023 Q4 | -24.29 Million AUD | -193.37% |
| 2023 Q2 | -15.99 Million AUD | -189.59% |
| 2022 Q4 | -11.65 Million AUD | -100.0% |
| 2022 FY | -23.92 Million AUD | -4835.81% |
| 2022 Q3 | -5.82 Million AUD | 29.56% |
| 2022 Q2 | -8.27 Million AUD | -100.0% |
| 2022 Q1 | -4.13 Million AUD | 0.0% |
| 2021 FY | -484.75 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 585.87% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -3135.487% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -695.016% |
| Biome Australia Limited | -1.91 Million AUD | -2367.535% |
| Patrys Limited | -3.53 Million AUD | -1233.932% |
| Orthocell Limited | -11.68 Million AUD | -304.155% |
| Imugene Limited | -140.93 Million AUD | 66.501% |
| Noxopharm Limited | -7.53 Million AUD | -526.541% |
| PYC Therapeutics Limited | -38.85 Million AUD | -21.496% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | -283.518% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -556.932% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -552.832% |
| Cynata Therapeutics Limited | -8.8 Million AUD | -435.993% |
| CSL Limited | 5.64 Billion AUD | 100.836% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -556.326% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -1441.565% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 196.056% |
| Starpharma Holdings Limited | -15.15 Million AUD | -211.431% |
| Nanollose Limited | -1.24 Million AUD | -3677.318% |
| Memphasys Limited | -2.7 Million AUD | -1645.927% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -2112.658% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -2195.575% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -966.896% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | -221.159% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -1542.779% |
| Race Oncology Limited | -13.38 Million AUD | -252.824% |
| Nyrada Inc. | -4.56 Million AUD | -935.229% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | -88.389% |
| PharmAust Limited | -6.65 Million AUD | -609.003% |
| Immutep Limited | -44.93 Million AUD | -5.058% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | -5.378% |
| Alterity Therapeutics Limited | -19.6 Million AUD | -140.846% |
| BTC Health Limited | 1.05 Million AUD | 4573.652% |
| Acrux Limited | -9.83 Million AUD | -380.068% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 120.893% |
| Biotron Limited | -5.15 Million AUD | -816.488% |
| Tissue Repair Ltd | -4.87 Million AUD | -868.219% |
| AdAlta Limited | -5.26 Million AUD | -797.254% |
| Hexima Limited | -1 Million AUD | -4580.036% |
| AnteoTech Limited | -11.72 Million AUD | -302.588% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 27.495% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | -114.092% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -928.719% |
| Actinogen Medical Limited | -12.83 Million AUD | -267.707% |
| Immuron Limited | -5.8 Million AUD | -713.806% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -732.449% |